Matthew Lee (@mslee_md) 's Twitter Profile
Matthew Lee

@mslee_md

Endourologist/Assistant Prof at OSU. HoLEP + PCNL. Fellowship at NM. Residency at UMich. Swammer. 🇰🇷🇺🇸Views are my own.

ID: 2839945336

linkhttp://www.dr-mattlee.com calendar_today21-10-2014 13:30:32

1,1K Tweet

1,1K Followers

899 Following

Matthew Lee (@mslee_md) 's Twitter Profile Photo

Dr Susana berrios from #UCSD comparing IRPs b/w various scopes (CVAC vs non CVAC). Comet pressure wire II. No difference in IRP b/w the 2 groups. Perhaps a function of non-CVAC group most used UAS? Great ?s from audience Boston Scientific Urology Roger Sur Ryan Hsi

Dr Susana berrios from #UCSD comparing IRPs b/w various scopes (CVAC vs non CVAC). Comet pressure wire II. No difference in IRP b/w the 2 groups. Perhaps a function of non-CVAC group most used UAS? Great ?s from audience <a href="/bsc_urology/">Boston Scientific Urology</a> <a href="/roger_sur/">Roger Sur</a> <a href="/StoneCrushed/">Ryan Hsi</a>
Mohammad Mohaghegh (@smmohagheghp) 's Twitter Profile Photo

Congrats to our students Benjamin Rubin and Sarah Kohl for their strong poster looking at BPH re operation rates nationwide. They just won the BPH poster session at AUA! UVM Medical Center UVM Urology Locky medicine UVM Larner Med Matthew Lee

Congrats to our students Benjamin Rubin and Sarah Kohl for their strong poster looking at BPH re operation rates nationwide. They just won the BPH poster session at AUA! 
<a href="/UVMMedCenter/">UVM Medical Center</a> <a href="/UVMUrology/">UVM Urology</a> <a href="/uvm/">Locky</a> medicine <a href="/UVMLarnerMed/">UVM Larner Med</a> <a href="/MSLee_MD/">Matthew Lee</a>
Matthew Lee (@mslee_md) 's Twitter Profile Photo

Kaylee Ferrara MA presenting results in non invasive pulsed electromagnetic field therapy for IC/BPS. Pilot results promising with 87.5% reporting ⬇️ pain, LUTS, ⬆️ mood/energy. Glad to see work for this difficult condition

Kaylee Ferrara MA presenting results in non invasive pulsed electromagnetic field therapy for IC/BPS. Pilot results promising with 87.5% reporting ⬇️ pain, LUTS, ⬆️ mood/energy. Glad to see work for this difficult condition
Matthew Lee (@mslee_md) 's Twitter Profile Photo

Dr Dean Elterman presenting results on RAPID II study rivermark flostent. 59 patients 18 month follow up. With sustained symptom relief and preserved sexual function #AUA2025

Dr <a href="/DrDeanElterman/">Dean Elterman</a> presenting results on RAPID II study rivermark flostent. 59 patients 18 month follow up. With sustained symptom relief and preserved sexual function #AUA2025
Perry Xu (@perryjxu) 's Twitter Profile Photo

Grateful for the opportunity to bring attention to this rising cohort of men. Finasteride 1mg is heavily marketed for male pattern baldness, but affects many facets of urology. For now, chronic finasteride 1mg use does not seem to be protective against BPH.

Amir Patel, MD (@amirpatelmd) 's Twitter Profile Photo

Pleasure discussing interim analyses for our ongoing RCTs Botox at time of HoLEP: improved symptom scores at 3 months HoLEP laser settings: No significant differences but greater passed same day void trials with 60Hz Amy Krambeck Perry Xu NM Urology #AUA2025

Pleasure discussing interim analyses for our ongoing RCTs

Botox at time of HoLEP: improved symptom scores at 3 months

HoLEP laser settings: No significant differences but greater passed same day void trials with 60Hz

<a href="/amy_krambeck/">Amy Krambeck</a> <a href="/perryjxu/">Perry Xu</a> <a href="/NM_Urology/">NM Urology</a> #AUA2025
Matthew Lee (@mslee_md) 's Twitter Profile Photo

Join us this AM! “When disaster strikes: managing nightmare cases in urology” plenary for endourology this AM #AUA2025

Join us this AM! “When disaster strikes: managing nightmare cases in urology” plenary for endourology this AM #AUA2025
Matthew Lee (@mslee_md) 's Twitter Profile Photo

Dr Khurshid Ghani presenting an update on SOUL trial and excellent update re: use of stents after URS. 73% of urologists in MUSIC place stent. 541 patients enrolled so far in SOUL. great trial to provide more evidence in this area Michigan Urology #AUA2025

Dr <a href="/peepeeDoctor/">Khurshid Ghani</a> presenting an update on SOUL trial and excellent update re: use of stents after URS. 73% of urologists in MUSIC place stent. 541 patients enrolled so far in SOUL. great trial to provide more evidence in this area <a href="/UMichUrology/">Michigan Urology</a> #AUA2025
Deepak Agarwal (@drdagarwal) 's Twitter Profile Photo

Matthew Lee highlights the rates of side effects of common drugs given for stone prevention Don’t forget to screen for these when prescribing! #AUA25

<a href="/MSLee_MD/">Matthew Lee</a> highlights the rates of side effects of common drugs given for stone prevention 

Don’t forget to screen for these when prescribing!

#AUA25
Perry Xu (@perryjxu) 's Twitter Profile Photo

Ryan Hsi finishing out #AUA2025 with a thought provoking presentation on machine learning and AI in urology. It’s a urologist’s responsibility to ask the important questions R.O.C.K. Society Amer. Urol. Assn.

<a href="/StoneCrushed/">Ryan Hsi</a> finishing out #AUA2025 with a thought provoking presentation on machine learning and AI in urology. It’s a urologist’s responsibility to ask the important questions <a href="/ROCKUrology/">R.O.C.K. Society</a> <a href="/AmerUrological/">Amer. Urol. Assn.</a>
Matthew Lee (@mslee_md) 's Twitter Profile Photo

A fantastic #AUA2025. Great seeing all and safe travels back home. Thank you to all the organizers for a fantastic meeting. Until #WCET2025 phoenix??

Austen Slade, MD, MBA (@austenslade) 's Twitter Profile Photo

Reimbursement and supply cost data being marketed by Procept to hospitals. CMSGov if you're listening (if there's anyone left) please make it make sense! While supply costs of their competitors are grossly overestimated to fit their narrative, I think we can all agree margins

Reimbursement and supply cost data being marketed by Procept to hospitals. <a href="/CMSGov/">CMSGov</a> if you're listening (if there's anyone left) please make it make sense! 

While supply costs of their competitors are grossly overestimated to fit their narrative, I think we can all agree margins
Mark Cuban (@mcuban) 's Twitter Profile Photo

This is exactly why PBMs should not be allowed to offer Formularies. Excluding zepbound is as pay for play as it gets, and has nothing to do with clinical value to patients. It takes the control of patient wellness out of the hands of doctors and patients and into the hands of

Ohio State WIMS (@ohiostatewims) 's Twitter Profile Photo

In the words of Maya Iyer, MD, MEd “We see you. We value you. We honor you.” Today we celebrate the extraordinary women professors and all faculty who uplift our community every day. Your impact, leadership, and brilliance do not go unnoticed. #WIMSAnnualCelebration The Ohio State University College of Medicine

In the words of <a href="/MayaIyerMD/">Maya Iyer, MD, MEd</a> “We see you. We value you. We honor you.”
Today we celebrate the extraordinary women professors and all faculty who uplift our community every day. Your impact, leadership, and brilliance do not go unnoticed. #WIMSAnnualCelebration
<a href="/OhioStateMed/">The Ohio State University College of Medicine</a>